BroadPharm Revenue and Competitors
Estimated Revenue & Valuation
- BroadPharm's estimated annual revenue is currently $4M per year.
- BroadPharm's estimated revenue per employee is $155,000
Employee Data
- BroadPharm has 26 Employees.
- BroadPharm grew their employee count by 13% last year.
BroadPharm's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Quality Control Laboratory Manager | Reveal Email/Phone |
4 | Marketing Manager | Reveal Email/Phone |
5 | Executive Assistant | Reveal Email/Phone |
6 | Research Scientist | Reveal Email/Phone |
7 | Office Associate | Reveal Email/Phone |
8 | Office Associate | Reveal Email/Phone |
BroadPharm Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is BroadPharm?
BroadPharm is a leading customer-focused biotech company in San Diego, California. We are dedicated to manufacturing and supplying high quality PEG Linkers, Click Chemistry reagents and advanced Bio-labeling reagents such as Dye Labeling and Biotin Labeling compounds to our clients worldwide. Founded in 2009, BroadPharm takes our customer needs as our highest priority. We have over 2,000 discrete, high purity PEG reagents in stock which can be shipped to our clients immediately. PEG is an abbreviation for Polyethylene Glycol which consists of repeating ethylene oxide units. Unlike traditional PEGs, all of BroadPharm’s PEG products represent a specific, single chemical structure with high purity. Each product is synthesized and purified using BroadPharm’s proprietary advanced technology and characterized by modern NMR and LC/MS. Broadpharm’s PEG products offer many advantages over traditional linkers such as high water solubility, reduced aggregation and low immunogenicity. These PEG reagents have been widely used in bioconjugation, antibody-drug conjugates (ADCs) therapeutic, drug delivery and diagnostics field. In addition, we also offer IP-protected custom synthesis and bio-conjugation services for our clients in the pharmaceutical and biotech industries. We provide timely technical support to address our client’s need and offer technical advice for the best use of our new products. With our strong expertise in modern chemistry, innovative & novel PEG technology and state-of-the-art equipment, BroadPharm can help our customers to accelerate their research through cost-effective and efficient solutions.
keywords:N/AN/A
Total Funding
26
Number of Employees
$4M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.9M | 26 | -4% | N/A |
#2 | $1.8M | 26 | -24% | $13.8M |
#3 | $1.7M | 26 | -38% | $90.1M |
#4 | $3.8M | 26 | -51% | $35.5M |
#5 | $2.6M | 26 | N/A | N/A |